Tag Archives: biotech industry

Podcast: Dr. Jeffrey Almond, Sanofi Pasteur, on the BioGENEius Challenge

BIOtechNOW’s Tracy Cooley talks to Dr. Almond, vice president of discovery and external R&D for Sanofi Pasteur, about the International BioGENEius Challenge, which will be presented at the upcoming BIO International Convention. Download the podcast

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Podcast: Renee Winsky, Tech Council of Maryland

Renee Winksy

BIOtechNOW’s Tracy Cooley talks to Renee Winsky, CEO of the Tech Council of Maryland about biotech in Maryland and the upcoming BIO International Convention in Washington, DC.

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

ISO: Biotech Humanitarian

We are looking for biotech humanitarians for our annual Biotech Humanitarian Award. The award recognizes an everyday hero who has helped to heal, fuel or feed the planet through their work in biotechnology. Know someone that you feel should be recognized for their good works? Nominate someone at www.iambiotech.org/award through January 31, 2010. 2009 Biotech Humanitarian Dr. Jay Keasling, was nominated by a colleague at the University of California at Berkley. Just think, you or your Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

The booming H1N1 vaccine market

The vaccine market is booming – and biotech companies are just one of the beneficiaries.  A recent Associated Press Article explains that an increase in government support and newer, better technologies are just a part of it.  Patients look to benefit from new vaccinations on the horizon for diseases such as Alzheimer’s, herpes, malaria, and perhaps even a universal flu vaccine. It was just last month at the BIO Investor Forum’s H1N1 panel that panelists Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , ,

Perspectives on today’s IPO candidates

Some speculation is coming back into the sector but most movement in public markets is specialist driven, not generalist driven. What will it take to get the generalist investors in? Unfortunately, most IPO stocks since 2005 have underperformed and have left a bad taste in the mouths of generalists. This has left generalists believing they cannot just come into the sector and purchase a basket of young biotechs. Example of a successful IPO: Targacept filed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,